Janku Filip 4
4 · Monte Rosa Therapeutics, Inc. · Filed Dec 19, 2022
Insider Transaction Report
Form 4
Janku Filip
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-12-15+36,000→ 36,000 totalExercise: $7.56Exp: 2032-10-02→ Common Stock (36,000 underlying)
Footnotes (2)
- [F1]On October 3, 2022, the Reporting Person was granted an option to purchase 36,000 shares of Common Stock, subject to the satisfaction of certain performance criteria. On December 15, 2022, the performance criteria underlying such shares were met.
- [F2]The shares underlying this option shall vest in full on June 15, 2024, subject to the Reporting Person's continued service on such date.